Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

Low levels of emotional awareness predict a better response to dermatological treatment in patients with psoriasis.

Consoli SM, Rolhion S, Martin C, Ruel K, Cambazard F, Pellet J, Misery L.

Dermatology. 2006;212(2):128-36.

PMID:
16484819
2.

[Alexithymia and psoriasis: a case-control study of 53 patients].

Masmoudi J, Maalej I, Masmoudi A, Rached H, Rebai A, Turki H, Jaoua A.

Encephale. 2009 Feb;35(1):10-7. doi: 10.1016/j.encep.2007.11.009. Epub 2008 Apr 2. French.

PMID:
19250988
3.

[French validation study of the levels of emotional awareness scale].

Bydlowski S, Corcos M, Paterniti S, Guilbaud O, Jeammet P, Consoli SM.

Encephale. 2002 Jul-Aug;28(4):310-20. French.

PMID:
12232540
4.

Emotional awareness deficits in inpatients of a psychosomatic ward: a comparison of two different measures of alexithymia.

Subic-Wrana C, Bruder S, Thomas W, Lane RD, Köhle K.

Psychosom Med. 2005 May-Jun;67(3):483-9.

PMID:
15911914
5.

Physical and psychologic measures are necessary to assess overall psoriasis severity.

Kirby B, Richards HL, Woo P, Hindle E, Main CJ, Griffiths CE.

J Am Acad Dermatol. 2001 Jul;45(1):72-6.

PMID:
11423838
6.

Emotional awareness in substance-dependent patients.

Carton S, Bayard S, Paget V, Jouanne C, Varescon I, Edel Y, Detilleux M.

J Clin Psychol. 2010 Jun;66(6):599-610. doi: 10.1002/jclp.20662.

PMID:
20186720
7.

Alexithymia and emotional awareness in females with Painful Rheumatic Conditions.

Baeza-Velasco C, Carton S, Almohsen C, Blotman F, Gély-Nargeot MC.

J Psychosom Res. 2012 Nov;73(5):398-400. doi: 10.1016/j.jpsychores.2012.08.008. Epub 2012 Aug 27.

PMID:
23062815
8.

The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients.

Devrimci-Ozguven H, Kundakci TN, Kumbasar H, Boyvat A.

J Eur Acad Dermatol Venereol. 2000 Jul;14(4):267-71.

PMID:
11204514
9.

[Emotion regulation among psychostimulants drug users at techno parties].

Lillaz C, Varescon I.

Encephale. 2012 Oct;38(5):390-6. doi: 10.1016/j.encep.2011.11.009. Epub 2012 Jan 5. French.

PMID:
23062452
10.

[Changes in alexithymia and emotional awareness during psychotherapeutic inpatient treatment].

Simson U, Martin K, Schäfer R, Franz M, Janssen P.

Psychother Psychosom Med Psychol. 2006 Sep-Oct;56(9-10):376-82. German.

PMID:
17031769
11.

Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.

Alora-Palli MB, Perkins AC, Van Cott A, Kimball AB.

Am J Clin Dermatol. 2010;11(4):275-83. doi: 10.2165/11530380-000000000-00000.

PMID:
20513160
12.

Association of psychic stress with clinical severity and symptoms of psoriatic patients.

Harvima RJ, Viinamäki H, Harvima IT, Naukkarinen A, Savolainen L, Aalto ML, Horsmanheimo M.

Acta Derm Venereol. 1996 Nov;76(6):467-71.

PMID:
8982414
13.

Initial experience with routine administration of etanercept in psoriasis.

de Groot M, Appelman M, Spuls PI, de Rie MA, Bos JD.

Br J Dermatol. 2006 Oct;155(4):808-14.

PMID:
16965432
14.

Low-dose, short-term ciclosporin (Neoral®) therapy is effective in improving patients' quality of life as assessed by Skindex-16 and GHQ-28 in mild to severe psoriasis patients.

Okubo Y, Natsume S, Usui K, Amaya M, Tsuboi R.

J Dermatol. 2011 May;38(5):465-72. doi: 10.1111/j.1346-8138.2010.01041.x. Epub 2010 Oct 6.

PMID:
21352289
15.

Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.

Feldman SR, Gordon KB, Bala M, Evans R, Li S, Dooley LT, Guzzo C, Patel K, Menter A, Gottlieb AB.

Br J Dermatol. 2005 May;152(5):954-60.

PMID:
15888152
16.

Emotion-processing deficits in eating disorders.

Bydlowski S, Corcos M, Jeammet P, Paterniti S, Berthoz S, Laurier C, Chambry J, Consoli SM.

Int J Eat Disord. 2005 May;37(4):321-9.

PMID:
15856501
17.

A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.

Poulalhon N, Begon E, Lebbé C, Lioté F, Lahfa M, Bengoufa D, Morel P, Dubertret L, Bachelez H.

Br J Dermatol. 2007 Feb;156(2):329-36.

PMID:
17223874
18.

[Clinical experience with etanercept in the treatment of psoriasis].

Martín B, Sánchez-Carazo JL, Pérez-Ferriols A, Laguna C, Oliver V, Alegre V.

Actas Dermosifiliogr. 2008 Sep;99(7):540-5. Spanish.

PMID:
18682167
19.

A global approach to psoriatic patients through PASI score and Skindex-29.

Prignano F, Ruffo G, Ricceri F, Pescitelli L, Lotti T.

G Ital Dermatol Venereol. 2011 Feb;146(1):47-52.

PMID:
21317856
20.

Insight in bipolar disorder: associations with cognitive and emotional processing and illness characteristics.

van der Werf-Eldering MJ, van der Meer L, Burger H, Holthausen EA, Nolen WA, Aleman A.

Bipolar Disord. 2011 Jun;13(4):343-54. doi: 10.1111/j.1399-5618.2011.00934.x.

PMID:
21843274

Supplemental Content

Support Center